BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38683455)

  • 1. NLRX1: a key regulator in mitochondrial respiration and colorectal cancer progression.
    Ding Y; Sun W; Han M; Liu Z; Kang H; Ma X; Wang J; Mu H; Huang Y; Hou S; Sun D; Shen X; Wu X; Liu R
    Med Oncol; 2024 Apr; 41(6):131. PubMed ID: 38683455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NLRX1 regulates TNF-α-induced mitochondria-lysosomal crosstalk to maintain the invasive and metastatic potential of breast cancer cells.
    Singh K; Roy M; Prajapati P; Lipatova A; Sripada L; Gohel D; Singh A; Mane M; Godbole MM; Chumakov PM; Singh R
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1460-1476. PubMed ID: 30802640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
    Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
    Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenylosuccinate lyase is oncogenic in colorectal cancer by causing mitochondrial dysfunction and independent activation of NRF2 and mTOR-MYC-axis.
    Taha-Mehlitz S; Bianco G; Coto-Llerena M; Kancherla V; Bantug GR; Gallon J; Ercan C; Panebianco F; Eppenberger-Castori S; von Strauss M; Staubli S; Bolli M; Peterli R; Matter MS; Terracciano LM; von Flüe M; Ng CKY; Soysal SD; Kollmar O; Piscuoglio S
    Theranostics; 2021; 11(9):4011-4029. PubMed ID: 33754045
    [No Abstract]   [Full Text] [Related]  

  • 5. NLRX1 acts as tumor suppressor by regulating TNF-α induced apoptosis and metabolism in cancer cells.
    Singh K; Poteryakhina A; Zheltukhin A; Bhatelia K; Prajapati P; Sripada L; Tomar D; Singh R; Singh AK; Chumakov PM; Singh R
    Biochim Biophys Acta; 2015 May; 1853(5):1073-86. PubMed ID: 25639646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-Myb promotes growth and metastasis of colorectal cancer through c-fos-induced epithelial-mesenchymal transition.
    Qu X; Yan X; Kong C; Zhu Y; Li H; Pan D; Zhang X; Liu Y; Yin F; Qin H
    Cancer Sci; 2019 Oct; 110(10):3183-3196. PubMed ID: 31338937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redox regulation by SOD2 modulates colorectal cancer tumorigenesis through AMPK-mediated energy metabolism.
    Zhou C; Lyu LH; Miao HK; Bahr T; Zhang QY; Liang T; Zhou HB; Chen GR; Bai Y
    Mol Carcinog; 2020 May; 59(5):545-556. PubMed ID: 32149414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone Demethylase JMJD2D Interacts With β-Catenin to Induce Transcription and Activate Colorectal Cancer Cell Proliferation and Tumor Growth in Mice.
    Peng K; Kou L; Yu L; Bai C; Li M; Mo P; Li W; Yu C
    Gastroenterology; 2019 Mar; 156(4):1112-1126. PubMed ID: 30472235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Properties and Clinical Relevance of Speckle-Type POZ Protein in Human Colorectal Cancer.
    Xu J; Wang F; Jiang H; Jiang Y; Chen J; Qin J
    J Gastrointest Surg; 2015 Aug; 19(8):1484-96. PubMed ID: 26022775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LACTB, a novel epigenetic silenced tumor suppressor, inhibits colorectal cancer progression by attenuating MDM2-mediated p53 ubiquitination and degradation.
    Zeng K; Chen X; Hu X; Liu X; Xu T; Sun H; Pan Y; He B; Wang S
    Oncogene; 2018 Oct; 37(41):5534-5551. PubMed ID: 29899406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disparate roles of CXCR3A and CXCR3B in regulating progressive properties of colorectal cancer cells.
    Li H; Rong S; Chen C; Fan Y; Chen T; Wang Y; Chen D; Yang C; Yang J
    Mol Carcinog; 2019 Feb; 58(2):171-184. PubMed ID: 30302818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-21 (Mir-21) Promotes Cell Growth and Invasion by Repressing Tumor Suppressor PTEN in Colorectal Cancer.
    Wu Y; Song Y; Xiong Y; Wang X; Xu K; Han B; Bai Y; Li L; Zhang Y; Zhou L
    Cell Physiol Biochem; 2017; 43(3):945-958. PubMed ID: 28957811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Innate Immune Receptor NLRX1 Functions as a Tumor Suppressor by Reducing Colon Tumorigenesis and Key Tumor-Promoting Signals.
    Koblansky AA; Truax AD; Liu R; Montgomery SA; Ding S; Wilson JE; Brickey WJ; Mühlbauer M; McFadden RM; Hu P; Li Z; Jobin C; Lund PK; Ting JP
    Cell Rep; 2016 Mar; 14(11):2562-75. PubMed ID: 26971998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1.
    Wang X; Lai Q; He J; Li Q; Ding J; Lan Z; Gu C; Yan Q; Fang Y; Zhao X; Liu S
    Int J Med Sci; 2019; 16(1):51-59. PubMed ID: 30662328
    [No Abstract]   [Full Text] [Related]  

  • 15. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
    Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
    J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic long intervening noncoding RNA Linc00284 promotes c-Met expression by sponging miR-27a in colorectal cancer.
    You J; Li J; Ke C; Xiao Y; Lu C; Huang F; Mi Y; Xia R; Li Q
    Oncogene; 2021 Jun; 40(24):4151-4166. PubMed ID: 34050266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of Met receptor pathway in aggressive behavior of colorectal cancer cells induced by parathyroid hormone-related peptide.
    Novoa Díaz MB; Carriere P; Gigola G; Zwenger AO; Calvo N; Gentili C
    World J Gastroenterol; 2022 Jul; 28(26):3177-3200. PubMed ID: 36051345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular Context Dictates the Suppression or Augmentation of Triple-Negative Mammary Tumor Metastasis by NLRX1.
    Nagai-Singer MA; Woolls MK; Leedy K; Hendricks-Wenger A; Brock RM; Coutermarsh-Ott S; Paul T; Morrison HA; Imran KM; Tupik JD; Fletcher EJ; Brown DA; Allen IC
    J Immunol; 2023 Dec; 211(12):1844-1857. PubMed ID: 37909827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ITGBL1 promotes migration, invasion and predicts a poor prognosis in colorectal cancer.
    Qiu X; Feng JR; Qiu J; Liu L; Xie Y; Zhang YP; Liu J; Zhao Q
    Biomed Pharmacother; 2018 Aug; 104():172-180. PubMed ID: 29772438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcription factor HOXC10 activates the expression of MTFR2 to regulate the proliferation, invasion and migration of colorectal cancer cells.
    Xie Y; Chen R; Yan L; Jia Z; Liang G; Wang Q
    Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34523692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.